e-learning
resources
ERJ
2017
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Assessing risk in pulmonary arterial hypertension: what we know, what we don't
Raymond L. Benza, Harrison W. Farber, Mona Selej, Mardi Gomberg-Maitland
Source:
Eur Respir J, 50 (2) 1701353; 10.1183/13993003.01353-2017
Journal Issue:
August
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Raymond L. Benza, Harrison W. Farber, Mona Selej, Mardi Gomberg-Maitland. Assessing risk in pulmonary arterial hypertension: what we know, what we don't. Eur Respir J, 50 (2) 1701353; 10.1183/13993003.01353-2017
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Pathophysiology of pulmonary hypertension: what the interested clinician needs to know
Source: ERS Course 2020 - Pulmonary hypertension and pulmonary vascular disease
Year: 2020
Image-based recommendations for the evaluation of pulmonary embolism and arterial hypertension: what? when? how?
Source: Virtual Congress 2020 – Image-based guidelines and recommendations in respiratory diseases
Year: 2020
Assessing pulmonary hypertension severity in lung disease is a key step to improving outcomes: embrace resistance and don't be pressurised to go with the flow
Source: Eur Respir J, 58 (2) 2102008; 10.1183/13993003.02008-2021
Year: 2021
Clinical trials in pulmonary arterial hypertension: what they tell us
Source: ERS Course 2020 - Pulmonary hypertension and pulmonary vascular disease
Year: 2020
Clinical trials in pulmonary arterial hypertension: what do they tell us
Source: ERS Skills course - Pulmonary hypertension and pulmonary vascular disease
Year: 2018
Clinical trials in pulmonary arterial hypertension: what do they tell us
Source: ERS Course 2017 - Pulmonary Hypertension and Pulmonary Vascular Disease
Year: 2017
“Rehab for all!” Is it too early in pulmonary arterial hypertension?
Source: Eur Respir J, 54 (5) 1901558; 10.1183/13993003.01558-2019
Year: 2019
Pulmonary hypertension: what can we learn from studies?
Source: International Congress 2015 – Practising personalised medicine: why, when, and how?
Year: 2015
Pulmonary hypertension: what does the pathology tell us?
Source: Annual Congress 2010 - PG4 Core Curriculum Postgraduate Course: Pathology for the clinician
Year: 2010
Thrombo-embolic pulmonary hypertension: which treatment should we choose? / Hypertension pulmonaire thrombo-embolique: quel traitement choisir ?
Source: International Congress 2018 – French Programme 2018: Part II
Year: 2018
Sex differences in pulmonary hypertension: are we cleaning up the mess?
Source: Eur Respir J 2016; 47: 390-393
Year: 2016
Pulmonary arterial hypertension among elderly patients: an emerging problem?
Source: Annual Congress 2007 - Pulmonary hypertension in the clinic
Year: 2007
Debating the new haemodynamic definition of pulmonary hypertension: much ado about nothing?
Source: Eur Respir J, 54 (2) 1901278; 10.1183/13993003.01278-2019
Year: 2019
New guidelines for chronic cough: what we know and what we don’t know
Source: International Congress 2019 – New clinical practice guidelines for chronic cough
Year: 2019
Treatment of pulmonary hypertension due to COPD: can we really hope in better?
Source: Eur Respir J 2005; 26: Suppl. 49, 562s
Year: 2005
Inflammation in pulmonary arterial hypertension: is it time to quell the fire?
Source: Eur Respir J 2014; 43: 685-688
Year: 2014
Goal-oriented therapy in paediatric pulmonary arterial hypertension: are we ready?
Source: Eur Respir J 2014; 44: 1404-1407
Year: 2014
CC6 Is it truly pulmonary arterial hypertension?
Source: Milan 2017 - Educational material
Year: 2017
What can the ECG tell us about pulmonary embolism?
Source: Eur Respir J 2004; 24: Suppl. 48, 274s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept